Studies have shown that high CXCR3 expression in tumor tissues suggests poor prognosis in breast cancer [28], colorectal cancer [29], kidney cancer [30], and ovarian cancer, and inhibition of CXCR3 expression can reduce the production of ovarian cancer ascites [31]. The gene discussed is CXCR3; the disease is neoplasm.